Meridian Bioscience
VIVO
#5216
Rank
A$2.24 B
Marketcap
A$51.12
Share price
0.00%
Change (1 day)
19.45%
Change (1 year)

Meridian Bioscience (VIVO) - Total debt

Total debt on the balance sheet as of September 2022 : A$46.58 Million

According to Meridian Bioscience's latest financial reports the company's total debt is A$46.58 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Meridian Bioscience - Total debt on balance sheet (from 1996 to 2022)

Total debt by year

Year Total debt Change
2022-09-30A$48.12 M-47.21%
2021-09-30A$91.16 M-13.23%
2020-09-30A$0.10 B-6.43%
2019-09-30A$0.11 B61.64%
2018-09-30A$69.46 M-0.27%
2017-09-30A$69.65 M-8.84%
2016-09-30A$76.4 M
2006-09-30A$2.41 M-43.35%
2005-09-30A$4.26 M-82.81%
2004-09-30A$24.81 M-26.29%
2003-09-30A$33.66 M-33.48%
2002-09-30A$50.6 M-23.09%
2001-09-30A$65.8 M2.24%
2000-09-30A$64.36 M58.04%
1999-09-30A$40.72 M16.1%
1998-09-30A$35.07 M22.26%
1997-09-30A$28.68 M-2.16%
1996-09-30A$29.32 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
QuidelOrtho
QDEL
A$4.27 B 9,086.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$53.69 B 115,156.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$29.10 B 62,376.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$3.79 B 8,048.40%๐Ÿ‡บ๐Ÿ‡ธ USA